Hepatitis C virus genotypes in patients on renal replacement therapy | Zendy

TaChien Chan | Zendy; J. Lau | Zendy; Patrick Wu | Zendy; ChingLung Lai | Zendy; A.S. Lok | Zendy; Ivy Cheng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hepatitis C virus genotypes in patients on renal replacement therapy

Author(s) -

TaChien Chan,

J. Lau,

Patrick Wu,

ChingLung Lai,

A.S. Lok,

Ivy Cheng

Publication year - 1998

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/13.3.731

Subject(s) - medicine , genotype , renal replacement therapy , hepatitis c virus , hepatitis c , kidney disease , population , dialysis , disease , epidemiology , immunology , liver disease , hemodialysis , virus , biology , gene , genetics , environmental health

Chronic hepatitis C virus (HCV) infection is prevalent among patients on renal replacement therapy. Viral genomic differences can contribute to diversities in clinical manifestation. The distribution of HCV genotypes depends on the geographical region and risk factors unique to the patient population. We determined the HCV genotypes in patients on renal replacement therapy in order to define the genotypic profile and examine the relationship between genotype, mode of renal replacement therapy, and the prevalence as well as severity of liver disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research